WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2006119540) PREPARATION FOR TREATING PSORIASIS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/119540    International Application No.:    PCT/AU2006/000575
Publication Date: 16.11.2006 International Filing Date: 03.05.2006
IPC:
A61K 31/122 (2006.01), A61K 31/17 (2006.01), A61K 31/19 (2006.01), A61K 31/60 (2006.01), A61K 35/04 (2006.01), A61P 17/02 (2006.01), A61P 17/06 (2006.01)
Applicants: NICOLOPOULOS, Jenny [AU/AU]; (AU)
Inventors: NICOLOPOULOS, Jenny; (AU)
Agent: SPRUSON & FERGUSON; GPO 3898, Sydney, NSW 2001 (AU)
Priority Data:
2005902378 11.05.2005 AU
Title (EN) PREPARATION FOR TREATING PSORIASIS
(FR) PREPARATION DESTINEE A TRAITER LE PSORIASIS
Abstract: front page image
(EN)There is disclosed herein a topical preparation for the treatment of psoriasis, the preparation comprising as active ingredients: therapeutically effective amounts of dithranol, tar, beta hydroxy acid, urea and an alpha-hydroxy acid, together with a suitable carrier. There is also disclosed herein the use of dithranol, tar, a beta hydroxy acid, urea and an alpha-hydroxy acid in the preparation of a topical medicament for treating psoriasis or for maintaining psoriasis remission.
(FR)L’invention concerne une préparation topique destinée au traitement du psoriasis, la préparation comportant en tant que principes actifs : des quantités thérapeutiquement efficaces de dithranol, de goudron, d’acide béta hydroxy, d’urée et d’acide alpha-hydroxy, conjugués à un excipient acceptable. L’invention se rapporte également ci-après à l’utilisation de dithranol, de goudron, d’un acide béta hydroxy, d’urée et d’un acide alpha-hydroxy dans la préparation d’un médicament topique destiné au traitement du psoriasis ou au maintien de la rémission du psoriasis.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)